Dietary intake of pterostilbene, a constituent of blueberries, inhibits the -catenin/p65 downstream signaling pathway and colon carcinogenesis in rats
Open Access
- 8 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 31 (7), 1272-1278
- https://doi.org/10.1093/carcin/bgq004
Abstract
Stilbenes are phytochemicals present in grapes, berries, peanuts and red wine. A widely studied stilbene, resveratrol ( trans -3,5,4′-trihydroxystilbene), has been shown to exert antioxidant, anti-inflammatory, chemopreventive and antiaging effects in a number of biological systems. We reported earlier that pterostilbene ( trans -3,5-dimethoxy-4′-hydroxystilbene), a structurally related stilbene found in blueberries, was effective in reducing the incidence and multiplicity of aberrant crypt foci formation in the colon of rats injected with azoxymethane (AOM). Our present study was to identify the chemopreventive potential of pterostilbene with colonic tumor formation as an end point and further to evaluate the mechanistic action of pterostilbene during colon carcinogenesis. F344 rats were given two AOM injections subcutaneously when they were 7 and 8 weeks old and continuously fed the control or 40 p.p.m. pterostilbene diet for 45 weeks. Overall analyses indicated that pterostilbene reduced colon tumor multiplicity of non-invasive adenocarcinomas, lowered proliferating cell nuclear antigen and downregulated the expression of β-catenin and cyclin D1. Pterostilbene decreased mucosal levels of the proinflammatory cytokines, tumor necrosis factor-α, interleukin (IL)-1β and IL-4. Colon tumors from pterostilbene-fed animals showed reduced expression of inflammatory markers as well as nuclear staining for phospho-p65, a key molecule in the nuclear factor-kappaB pathway. In HT-29 cells, pterostilbene reduced the protein levels of β-catenin, cyclin D1 and c-MYC, altered the cellular localization of β-catenin and inhibited the phosphorylation of p65. Our data with pterostilbene in suppressing colon tumorigenesis, cell proliferation as well as key inflammatory markers in vivo and in vitro suggest the potential use of pterostilbene for colon cancer prevention.Keywords
This publication has 52 references indexed in Scilit:
- Anti-inflammatory Action of Pterostilbene Is Mediated through the p38 Mitogen-Activated Protein Kinase Pathway in Colon Cancer CellsCancer Prevention Research, 2009
- International Trends in Colorectal Cancer Incidence RatesCancer Epidemiology, Biomarkers & Prevention, 2009
- Nuclear cyclin D1: An oncogenic driver in human cancerJournal of Cellular Physiology, 2009
- Ser276 Phosphorylation of NF-kB p65 by MSK1 Controls SCF Expression in InflammationPLOS ONE, 2009
- Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancerGenome Biology, 2007
- The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionMolecular Cancer, 2007
- Celecoxib for the Prevention of Colorectal Adenomatous PolypsThe New England Journal of Medicine, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitorCancer Letters, 2000